Cloud-clone
SKU(재고 관리 코드):LMD982Hu
Magnetic Luminex Assay Kit for Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) ,etc.
Magnetic Luminex Assay Kit for Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) ,etc.
Product No.
LMD982Hu
Organism Species
Homo sapiens (Human).
Sample Type
Tissue homogenates, cell lysates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3.5h
Detection Range
0.01-10ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.003 ng/mL.
UOM
1Plex 2Plex 3Plex 4Plex 5Plex 6Plex 7Plex 8Plex
Specificity
This assay has high sensitivity and excellent specificity for detection of Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) ,etc..
No significant cross-reactivity or interference between Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) ,etc. and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) ,etc. and the recovery rates were calculated by comparing the measured value to the expected amount of Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) ,etc. in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 85-101 | 93 |
| EDTA plasma(n=5) | 84-97 | 90 |
| heparin plasma(n=5) | 78-98 | 95 |
| sodium citrate plasma(n=5) | 97-105 | 101 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) ,etc. were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) ,etc. were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) ,etc. and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 88-99% | 83-102% | 84-91% | 80-90% |
| EDTA plasma(n=5) | 94-102% | 79-96% | 94-102% | 86-95% |
| heparin plasma(n=5) | 95-103% | 89-98% | 88-95% | 99-105% |
| sodium citrate plasma(n=5) | 80-89% | 92-99% | 78-103% | 87-96% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| 96-well plate | 1 | Plate sealer for 96 wells | 4 |
| Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
| Pre-Mixed Magnetic beads (22#:DDAH1) | 1 | Analysis buffer | 1×20mL |
| Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
| Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
| Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
| Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
| Magazine | Citations |
| The Journal of Physiology | Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute toendothelial dysfunction related to insulin resistance in rats and morbidly obese humans. pubmed:26840628 |
| Frontiers in Pharmacology | Promotes Endothelial Nitric Oxide Production by Reducing Asymmetric Dimethylarginine in Tumor Necrosis Factor-α-Induced Human Umbilical Vein … Pubmed: 31607906 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPD982Hu01 | Recombinant Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAD982Hu01 | Polyclonal Antibody to Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) | WB; IHC; ICC; IP. |
| MAD982Hu21 | Monoclonal Antibody to Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) | WB; IHC; ICC; IP. |
| SED982Hu | ELISA Kit for Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMD982Hu | Magnetic Luminex Assay Kit for Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
